Austin Cosgrove

Harvard Pilgrim Health Care Institute, United States

Disclosure information not submitted.

Presentation(s):

• 1D-05 - Rapid Surveillance Study to Evaluate Safety of Respiratory Syncytial Virus (RSV) Vaccine (ABRYSVO™) Exposure During Pregnancy in the United States

  Sunday, August 24, 2025
  11:30 AM - 11:45 AM ET